Simon J. Harrison, MBBS, MRCP(uk), FRCPath(uk), FRACP, PhD (he/him/his)

Director, Centre of Excellence in Cellular Immunotherapy
Peter MacCallum Cancer Centre
Melbourne, Australia

Prof Simon Harrison is the Director, Centre of Excellence for Cellular Immunotherapy at VCCC and the Peter MacCallum Cancer Centre, Director of Clinical Apheresis, and a clinician scientist in the Sir Peter MacCallum department of Oncology in Melbourne University. He is a leading Australia Myeloma clinician and chair of the Myeloma Scientific Advisory Group at Myeloma Australia

Clinical research: Prof Harrison’s clinical research is focused in the field of multiple myeloma examining novel therapies including novel drug combinations, early phase clinical trial design, the incorporation of novel biomarkers into clinical protocols and cellular immunotherapy therapy.

Laboratory research: Prof Harrison’s work focuses on the immunopathology of multiple myeloma, the impact of novel drug combinations and cellular immune therapies and in vivo cell tracking. He is also a lead in the development of POL1 inhibitors in combination with other novel drugs to target ribosome biogenesis.

Presentation(s):

• Abstract Session 5: Immune Therapies

  Friday, September 29, 2023
  4:30 PM – 5:30 PM EEST

• OA-05: Efficacy of forimtamig, a GPRC5DxCD3 bispecific antibody, in patients with relapsed/refractory multiple myeloma (RRMM): analysis of patient- and disease-related factors associated with responses

  Friday, September 29, 2023
  4:30 PM – 4:42 PM EEST